Researchers unveil pioneering approach to combat age-related vision loss

IRAK-M expression in human RPE and retina. Credit: Liu et al. / Science Translational Medicine Cirrus Therapeutics, the University of Bristol, and London’s Global University Institute of Ophthalmology have discovered a new treatment for age-related macular degeneration (AMD), the leading cause of vision loss among older adults. Featured on the cover of the journal Science Translational Medicine, this research reveals that boosting a specific protein, IRAK-M, in retinal cells could offer a new and highly effective therapy for AMD. AMD can severely impact a person’s vision. Patients suffering from AMD Read More

Related posts:

  1. Discovery could help with early detection of vision loss in age-related macular degeneration
  2. Pioneering approach to safe, verifiable humanoid walking
  3. Researchers unveil impact of east Asian gene variant on type 2 diabetes risk
  4. ‘I keep away from people’—combined vision and hearing loss is isolating more and more older Australians
  5. Researchers create winning strategy to combat vaccine misinformation on X
  6. Switch up teaching and assessment to help teachers combat chatbot-cheating, say researchers
  7. Researchers discover promising approach to prevent recurrence of breast cancer
  8. Loneliness increases risk of age-related memory loss, finds study

Leave a Reply

Your email address will not be published. Required fields are marked *